Discussions on “Plausibility”
In view of the current discussions on “plausibility”, in particular in the areas of chemistry and life sciences and as background for the upcoming EPO Enlarged Board of Appeal decision G 2/21 we “reload” an earlier article by our partner Holger Tostmann that was first published in the American Chemical Society’s Medicinal Chemistry Letters (ACS Med. Chem. Lett. 2015, 6, 364−366).
Dr. Holger Tostmann
Legal Expertise
